GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (NYSE:ABBV) » Definitions » Cyclically Adjusted PB Ratio

ABBV (AbbVie) Cyclically Adjusted PB Ratio : 48.34 (As of May. 30, 2025)


View and export this data going back to 2012. Start your Free Trial

What is AbbVie Cyclically Adjusted PB Ratio?

As of today (2025-05-30), AbbVie's current share price is $186.11. AbbVie's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $3.85. AbbVie's Cyclically Adjusted PB Ratio for today is 48.34.

The historical rank and industry rank for AbbVie's Cyclically Adjusted PB Ratio or its related term are showing as below:

ABBV' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 33.47   Med: 44.96   Max: 57.36
Current: 47.96

During the past years, AbbVie's highest Cyclically Adjusted PB Ratio was 57.36. The lowest was 33.47. And the median was 44.96.

ABBV's Cyclically Adjusted PB Ratio is ranked worse than
99.41% of 683 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs ABBV: 47.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AbbVie's adjusted book value per share data for the three months ended in Mar. 2025 was $0.804. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.85 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AbbVie's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Cyclically Adjusted PB Ratio Chart

AbbVie Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.43 45.74 50.43 41.86 46.62

AbbVie Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.11 45.19 52.00 46.62 54.38

Competitive Comparison of AbbVie's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Cyclically Adjusted PB Ratio falls into.


;
;

AbbVie Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AbbVie's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=186.11/3.85
=48.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, AbbVie's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.804/134.9266*134.9266
=0.804

Current CPI (Mar. 2025) = 134.9266.

AbbVie Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.325 100.684 4.456
201509 2.975 100.392 3.998
201512 2.450 99.792 3.313
201603 2.871 100.470 3.856
201606 3.463 101.688 4.595
201609 3.981 101.861 5.273
201612 2.911 101.863 3.856
201703 3.141 102.862 4.120
201706 3.770 103.349 4.922
201709 4.190 104.136 5.429
201712 3.201 104.011 4.152
201803 2.239 105.290 2.869
201806 -2.229 106.317 -2.829
201809 -1.942 106.507 -2.460
201812 -5.711 105.998 -7.270
201903 -5.294 107.251 -6.660
201906 -5.794 108.070 -7.234
201909 -5.563 108.329 -6.929
201912 -5.526 108.420 -6.877
202003 -5.021 108.902 -6.221
202006 8.337 108.767 10.342
202009 8.650 109.815 10.628
202012 7.408 109.897 9.095
202103 7.765 111.754 9.375
202106 7.113 114.631 8.372
202109 7.665 115.734 8.936
202112 8.713 117.630 9.994
202203 9.216 121.301 10.251
202206 8.288 125.017 8.945
202209 9.044 125.227 9.745
202212 9.753 125.222 10.509
202303 7.525 127.348 7.973
202306 7.290 128.729 7.641
202309 6.850 129.860 7.117
202312 5.867 129.419 6.117
202403 4.535 131.776 4.643
202406 3.838 132.554 3.907
202409 3.413 133.029 3.462
202412 1.884 133.157 1.909
202503 0.804 134.927 0.804

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (NYSE:ABBV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AbbVie Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie Business Description

Industry
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Executives
Jeffrey Ryan Stewart officer: SVP, US Commercial Operations 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Scott T Reents officer: SVP, Chief Financial Officer 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Kevin K Buckbee officer: SVP, Controller 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Timothy J. Richmond officer: EVP, Chief HR Officer 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Perry C Siatis officer: EVP, GC and Secretary 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Richard A Gonzalez officer: Chairman of the Board and CEO 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Nicholas Donoghoe officer: SVP, Enterprise Innovation 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Robert A. Michael officer: VP, Controller 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Azita Saleki-gerhardt officer: SVP, Operations 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Susan E Quaggin director 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jennifer L. Davis director 1 PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Elaine K. Sorg officer: Sr. V.P., U.S. Commercial Ops. 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Carrie C Strom officer: SVP & Pres Global Allerg Aesth 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Roxanne S Austin director 200 N SEPULVEDA BLVD, PO BOX 956 MS ES/001/A102, EL SEGUNDO CA 90245
Michael Severino officer: EVP, R&D and CSO 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064